11528011000001106: Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Cabergoline\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ergoline derivative\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Cabergoline\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Cabergoline\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing cabergoline\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing cabergoline in oral dose form (medicinal product form)\Product containing only cabergoline in oral dose form (medicinal product form)\Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet\Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

42260601000001117 Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

42260701000001110 Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Is a	Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Has active ingredient	Cabergoline	false	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Has specific active ingredient	Cabergoline	true	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd) 16 tablet	Is pack of	False	Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd) 16 tablet	Has AMP	True	Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
42260601000001117	Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
42260701000001110	Cabergoline 4mg tablets (A A H Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module